The price issue is a big explanation that BYD is significantly providing Tesla a run for its money. Many years ago, again in 2011 —Michael Forbes, CEO of Adastra, mentioned in his First press launch: “Hurt reduction is actually a critically crucial and mainstream matter, and we're remaining on the forefront of drug laws throughout the board.”